Role of circulating tumour marker CA 19.9 and antiangiogenic therapy with bevacizumab in patients with metastatic colorectal cancer on first line systemic treatment
Abstract
Publication Date:
2008
Iris type:
1.5 Abstract in rivista
List of contributors:
Formica, V; Portarena, I; Fiaschetti, V; Del Vecchio, G.; Massara, M.; Sica, G.; Sileri, P; Grenga, I; Pallone, F.; Roselli, M.
Published in: